Ghana vs Senegal: Contraceptive prevalence, any modern method
Contraceptive prevalence, any modern method over time
- Ghana
- Senegal
How they compare
Ghana currently reports 27.8% against 25.6% in Senegal, a difference of 2.2%.
That makes Ghana's figure about 1.1 times Senegal's.
The two have swapped places 1 time across 8 shared years of data; in 1993 it was Ghana ahead.
Ghana ranks 86th and Senegal ranks 88th of 113 countries.
Ghana has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ghana | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 10.1% | 4.8% | 5.3% | Ghana |
| 2010s | 23.8% | 20.6% | 3.1% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher contraceptive prevalence, any modern method, Ghana or Senegal?
- Ghana, at 27.8% against 25.6% in Senegal as of 2022.
- What is the difference in contraceptive prevalence, any modern method between Ghana and Senegal?
- 2.2%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Senegal?
- 8 years are reported by both, from 1993 to 2018.
- How do Ghana and Senegal rank globally for contraceptive prevalence, any modern method?
- Ghana ranks 86th and Senegal ranks 88th of 113 countries.
- Where does this data come from?
- Household surveys, United Nations (UN), note: Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as Contraceptive prevalence, any modern method (% of married women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Contraceptive prevalence, any modern method is the percentage of married women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.